AbbVie
ABBV
#30
Rank
ยฃ242.50 B
Marketcap
ยฃ137.23
Share price
0.10%
Change (1 day)
13.05%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of September 2024 : ยฃ56.26 Billion

According to AbbVie's latest financial reports the company's total debt is ยฃ56.26 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31ยฃ46.61 B-10.87%
2022-12-31ยฃ52.29 B-7.94%
2021-12-31ยฃ56.80 B-10.02%
2020-12-31ยฃ63.13 B24.07%
2019-12-31ยฃ50.88 B60.24%
2018-12-31ยฃ31.75 B14.85%
2017-12-31ยฃ27.64 B-7.4%
2016-12-31ยฃ29.85 B39.71%
2015-12-31ยฃ21.37 B122.16%
2014-12-31ยฃ9.61 B7.78%
2013-12-31ยฃ8.92 B-7.95%
2012-12-31ยฃ9.69 B31297.55%
2011-12-31ยฃ30.88 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ยฃ52.73 B-6.28%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ40.68 B-27.69%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ24.63 B-56.22%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ47.80 B-15.03%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ18.40 B-67.29%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.26 B-90.64%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ17.01 B-69.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ24.98 B-55.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ0.19 B-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA